Literature DB >> 17132243

Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration.

Erin A Kolbrich1, Allan J Barnes, David A Gorelick, Susan J Boyd, Edward J Cone, Marilyn A Huestis.   

Abstract

Cocaine is rapidly metabolized to major metabolites, benzoylecgonine (BE) and ecgonine methyl ester (EME), and minor metabolites, norcocaine, p-hydroxycocaine, m-hydroxycocaine, p-hydroxybenzoylecgonine (pOHBE), and m-hydroxybenzoylecgonine. This IRB-approved study examined cocaine and metabolite plasma concentrations in 18 healthy humans who provided written informed consent to receive low (75 mg/70 kg) and high (150 mg/70 kg) subcutaneous cocaine hydrochloride doses. Plasma specimens, collected prior to and up to 48 h after dosing, were analyzed by gas chromatography-mass spectrometry (2.5 ng/mL limits of quantification). Cocaine was detected within 5 min, with mean+/-SE peak concentrations of 300.4+/-24.6 ng/mL (low) and 639.1+/-56.8 ng/mL (high) 30-40 min after dosing. BE and EME generally were first detected in plasma 5-15 min post-dose; 2-4 h after dosing, BE and EME reached mean maximum concentrations of 321.3+/-18.4 (low) and 614.7+/-46.0 ng/mL (high) and 47.4+/-3.0 (low) and 124.4+/-18.2 ng/mL (high), respectively. Times of last detection were BE>EME>cocaine. Minor metabolites were detected much less frequently for up to 32 h, with peak concentrations<or=18 ng/mL for all analytes except pOHBE (up to 57.7 ng/mL). These data improve our knowledge of the pharmacokinetics of cocaine and its major and minor metabolites in plasma following controlled subcutaneous cocaine administration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132243     DOI: 10.1093/jat/30.8.501

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  17 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Revisiting a physiologically based pharmacokinetic model for cocaine with a forensic scope.

Authors:  María Elena Bravo-Gómez; Laura Nayeli Camacho-García; Luz Alejandra Castillo-Alanís; Miguel Ángel Mendoza-Meléndez; Alejandra Quijano-Mateos
Journal:  Toxicol Res (Camb)       Date:  2019-03-13       Impact factor: 3.524

Review 3.  Bioanalytical procedures for monitoring in utero drug exposure.

Authors:  Teresa Gray; Marilyn Huestis
Journal:  Anal Bioanal Chem       Date:  2007-03-17       Impact factor: 4.142

4.  Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration.

Authors:  Karl B Scheidweiler; Erin A Kolbrich Spargo; Tamsin L Kelly; Edward J Cone; Allan J Barnes; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2010-10       Impact factor: 3.681

5.  Bioavailability and Pharmacokinetics of Oral Cocaine in Humans.

Authors:  Marion A Coe; Rebecca A Jufer Phipps; Edward J Cone; Sharon L Walsh
Journal:  J Anal Toxicol       Date:  2018-06-01       Impact factor: 3.367

6.  Computational Systems Pharmacology-Target Mapping for Fentanyl-Laced Cocaine Overdose.

Authors:  Jin Cheng; Siyi Wang; Weiwei Lin; Nan Wu; Yuanqiang Wang; Maozi Chen; Xiang-Qun Xie; Zhiwei Feng
Journal:  ACS Chem Neurosci       Date:  2019-07-15       Impact factor: 4.418

7.  Simultaneous determination of L-tetrahydropalmatine and cocaine in human plasma by simple UPLC-FLD method: application in clinical studies.

Authors:  Mingming Yu; Hazem E Hassan; Ahmed Ibrahim; Kenneth S Bauer; Deanna L Kelly; Jia Bei Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-06-20       Impact factor: 3.205

8.  Cocaine and metabolite concentrations in DBS and venous blood after controlled intravenous cocaine administration.

Authors:  Kayla N Ellefsen; Jose Luiz da Costa; Marta Concheiro; Sebastien Anizan; Allan J Barnes; Sandrine Pirard; David A Gorelick; Marilyn A Huestis
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

9.  Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.

Authors:  Sharon L Walsh; William W Stoops; David E Moody; Shen-Nan Lin; George E Bigelow
Journal:  Exp Clin Psychopharmacol       Date:  2009-08       Impact factor: 3.157

Review 10.  Oral fluid testing for drugs of abuse.

Authors:  Wendy M Bosker; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-09-10       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.